Key Influencer in the Fatty Liver Treatment Market 2025: Increase In Alcohol Consumption Driver

What combination of drivers is leading to accelerated growth in the fatty liver treatment market?
The escalation in the intake of alcohol is anticipated to fuel the expansion of the fatty liver treatment market. The phrase "alcohol consumption" alludes to drinking liquor-containing beverages, a psychoactive substance known for its depressive effects on the central nervous system. The condition of the fatty liver disease could be exacerbated by excessive alcohol consumption, leading to more critical liver disorders, including alcoholic fatty liver disease (AFLD) and alcoholic hepatitis. For instance, the HRB National Drugs Library, a government-funded organization based in Ireland, reported in March 2023 that the alcohol consumption in Scotland saw an increase to 10.2 liters of pure alcohol per capita for individuals aged 15 and above in 2022, indicating a 7.6% increase as compared to 2021. This underscores a worrisome rise in alcohol consumption despite persistent public health initiatives to decrease intake. Consequently, this surge in alcohol consumption is propelling the expansion of the fatty liver treatment market.

Get Your Fatty Liver Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

What is the projected compound annual growth rate (CAGR) of the fatty liver treatment market from 2025 to 2034, and what factors influence it?
There has been a significant expansion in the size of the fatty liver treatment market recently. The market which is predicted to rise from $23.73 billion in 2024 to $25.12 billion in 2025, will do so at a compound annual growth rate (CAGR) of 5.8%. Factors like the obesity outbreak, inactive ways of living, unhealthy food habits, insufficient treatment alternatives, and awareness efforts, are considered to have contributed to the growth in the historic period.

In the coming years, the market for fatty liver treatment is anticipated to witness substantial growth, reaching a valuation of $33.07 billion by 2029 with a compound annual growth rate (CAGR) of 7.1%. This projected growth during the forecast period can be linked to factors such as a rise in the prevalence of the disease, an increase in healthcare spending, the escalation of diabetes and metabolic syndrome, and developments in therapeutic methods. The forecast period will also see major trends like the application of precision medicine, implementation of lifestyle change programs, the use of targeted therapies for Nash, non-invasive monitoring instruments, and technological progresses.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12581&type=smp

What new trends are reshaping the fatty liver treatment market and its opportunities?
The rising trend in the fatty liver treatment market essentially revolves around product innovation. To fortify their market standing, leading companies in the sector are creating groundbreaking products. For example, Akero Therapeutics, a biotechnology firm based in the US, successfully completed Phase II trials of their novel product, efruxifermin, in March 2023. This is used for treating nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) identified through non-invasive diagnosis. An exceptional Fc-FGF21 fusion protein, efruxifermin imitates the natural function of fibroblast growth factor 21 (FGF21), controlling a host of metabolic pathways and cellular operations.

What are the major segments of the fatty liver treatment market and their role in driving growth?
The fatty liver treatment market covered in this report is segmented -

1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants, Chemotherapy Drugs, Targeted Therapy, Vaccines, Anti-Viral Drugs
2) By Disease Type: Hepatitis, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Other Diseases
3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users

Subsegments:
1) By Anti-Rejection Drugs Or Immunosuppressants: Corticosteroids, Calcineurin Inhibitors, mTOR Inhibitors
2) By Chemotherapy Drugs: Conventional Chemotherapy Agents, Novel Chemotherapeutics Under Investigation
3) By Targeted Therapy: Small Molecule Inhibitors, Monoclonal Antibodies
4) By Vaccines: Therapeutic Vaccines, Preventive Vaccines
5) By Anti-Viral Drugs: Direct-Acting Antivirals (DAAs), Nucleos(t)ide Analogs

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12581

Which regions are key players in the growth of the fatty liver treatment market?
North America was the largest region in the fatty liver treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the key firms paving the way for growth in the fatty liver treatment market?
Major companies operating in the fatty liver treatment market include Pfizer Inc., Johnson & Johnson Services Inc., Hoffmann La Roche Ltd., AstraZeneca plc, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., The Bristol-Myers Squibb Company, GlaxoSmithkline plc, Mitsubishi Chemical Holdings, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Novo Nordisk A/S, Eisai Co. Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, GW Pharmaceuticals Limited, Retrophin Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., AbbKine Scientific Co. Ltd., Daewoong Co. Ltd., Madrigal Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Limited, Genfit, NGM Biopharmaceuticals Inc., Cardax Inc., Conatus Pharmaceuticals Inc., Limerick Biopharma Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12581&type=smp

What Is Covered In The Fatty Liver Treatment Global Market Report?

• Market Size Forecast: Examine the fatty liver treatment market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the fatty liver treatment market for a structured understanding.
• Key Players Overview: Analyze major players in the fatty liver treatment market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the fatty liver treatment market.
• Segment Contributions: Evaluate how different segments drive overall growth in the fatty liver treatment market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the fatty liver treatment market.
• Industry Challenges: Identify potential risks and obstacles affecting the fatty liver treatment market.
• Competitive Landscape: Review strategic developments in the fatty liver treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.